• Something wrong with this record ?

Prediction of non-resectability in tubo-ovarian cancer patients using Peritoneal Cancer Index - A prospective multicentric study using imaging (ISAAC study)

P. Pinto, F. Moro, JL. Alcázar, S. Alessi, G. Avesani, K. Benesova, A. Burgetova, G. Calareso, V. Chiappa, D. Cibula, A. Fagotti, D. Franchi, F. Frühauf, J. Jarkovsky, R. Kocian, L. Lambert, M. Masek, C. Panico, P. Pricolo, G. Scambia, J. Slama,...

. 2024 ; 191 (-) : 132-142. [pub] 20241010

Language English Country United States

Document type Journal Article, Multicenter Study, Observational Study

Persistent link   https://www.medvik.cz/link/bmc25003226

BACKGROUND: The aim was to evaluate the performance of the Peritoneal Cancer Index (PCI) using imaging (ultrasound, contrast-enhanced computed tomography (CT), and whole-body diffusion-weighted magnetic resonance imaging (WB-DWI/MRI) in assessing peritoneal carcinomatosis and predicting non-resectability in tubo-ovarian carcinoma patients. METHODS: This was a prospective multicenter observational study. We considered all patients with suspected primary ovarian/tubal/peritoneal cancer who underwent preoperative ultrasound, CT, and WB-DWI/MRI (if available). The optimal cut off value for assessing the performance of the methods in predicting non-resectability was identified at the point at which the sensitivity and specificity were most similar. The reference standard to predict non-resectability was surgical outcome in terms of residual disease >1 cm or surgery not feasible. Agreement between imaging methods and surgical exploration in assessing sites included in the PCI score was evaluated using the Intraclass Correlation Coefficient (ICC). RESULTS: 242 patients were included from January 2020 until November 2022. The optimal PCI cut-off for predicting non-resectability for surgical exploration was >12, which achieved the best AUC of 0.87, followed by ultrasound with a cut-off of >10 and AUC of 0.81, WB-DWI/MRI with a cut-off of >12 and AUC of 0.81, and CT with a cut-off of >11 and AUC of 0.74. Using ICC, ultrasound had very high agreement (0.94) with surgical PCI, while CT and WB-DWI/MRI had high agreement (0.86 and 0.87, respectively). CONCLUSION: Ultrasound performed by an expert operator had the best agreement with surgical findings compared to WB-DWI/MRI and CT in assessing radiological PCI. In predicting non-resectability, ultrasound was non-inferior to CT, while its non-inferiority to WB-DWI/MRI was not demonstrated.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003226
003      
CZ-PrNML
005      
20250206104202.0
007      
ta
008      
250121e20241010xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ygyno.2024.10.003 $2 doi
035    __
$a (PubMed)39393218
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pinto, Patrícia $u Department of Gynecology, Portuguese Institute of Oncology of Lisbon Francisco Gentil, Lisbon, Portugal; First Faculty of Medicine, Charles University and General University Hospital in Prague
245    10
$a Prediction of non-resectability in tubo-ovarian cancer patients using Peritoneal Cancer Index - A prospective multicentric study using imaging (ISAAC study) / $c P. Pinto, F. Moro, JL. Alcázar, S. Alessi, G. Avesani, K. Benesova, A. Burgetova, G. Calareso, V. Chiappa, D. Cibula, A. Fagotti, D. Franchi, F. Frühauf, J. Jarkovsky, R. Kocian, L. Lambert, M. Masek, C. Panico, P. Pricolo, G. Scambia, J. Slama, AC. Testa, AMV. Urbinati, JV. Garcia, R. Vigorito, D. Fischerová
520    9_
$a BACKGROUND: The aim was to evaluate the performance of the Peritoneal Cancer Index (PCI) using imaging (ultrasound, contrast-enhanced computed tomography (CT), and whole-body diffusion-weighted magnetic resonance imaging (WB-DWI/MRI) in assessing peritoneal carcinomatosis and predicting non-resectability in tubo-ovarian carcinoma patients. METHODS: This was a prospective multicenter observational study. We considered all patients with suspected primary ovarian/tubal/peritoneal cancer who underwent preoperative ultrasound, CT, and WB-DWI/MRI (if available). The optimal cut off value for assessing the performance of the methods in predicting non-resectability was identified at the point at which the sensitivity and specificity were most similar. The reference standard to predict non-resectability was surgical outcome in terms of residual disease >1 cm or surgery not feasible. Agreement between imaging methods and surgical exploration in assessing sites included in the PCI score was evaluated using the Intraclass Correlation Coefficient (ICC). RESULTS: 242 patients were included from January 2020 until November 2022. The optimal PCI cut-off for predicting non-resectability for surgical exploration was >12, which achieved the best AUC of 0.87, followed by ultrasound with a cut-off of >10 and AUC of 0.81, WB-DWI/MRI with a cut-off of >12 and AUC of 0.81, and CT with a cut-off of >11 and AUC of 0.74. Using ICC, ultrasound had very high agreement (0.94) with surgical PCI, while CT and WB-DWI/MRI had high agreement (0.86 and 0.87, respectively). CONCLUSION: Ultrasound performed by an expert operator had the best agreement with surgical findings compared to WB-DWI/MRI and CT in assessing radiological PCI. In predicting non-resectability, ultrasound was non-inferior to CT, while its non-inferiority to WB-DWI/MRI was not demonstrated.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a peritoneální nádory $x diagnostické zobrazování $7 D010534
650    _2
$a prospektivní studie $7 D011446
650    _2
$a lidé středního věku $7 D008875
650    12
$a nádory vaječníků $x diagnostické zobrazování $x patologie $x chirurgie $7 D010051
650    _2
$a senioři $7 D000368
650    12
$a počítačová rentgenová tomografie $x metody $7 D014057
650    12
$a ultrasonografie $x metody $7 D014463
650    _2
$a nádory vejcovodů $x diagnostické zobrazování $x patologie $x chirurgie $7 D005185
650    _2
$a difuzní magnetická rezonance $x metody $7 D038524
650    _2
$a dospělí $7 D000328
650    _2
$a prediktivní hodnota testů $7 D011237
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Moro, Francesca $u Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Rome, Italy
700    1_
$a Alcázar, Juan Luis $u QuironSalud Hospital, Málaga, Spain; Department of Obstetrics and Gynecology, Clínica Universidad de Navarra, Pamplona, Spain
700    1_
$a Alessi, Sarah $u Division of Radiology, IEO European Institute of Oncology IRCCS, Milan, Italy
700    1_
$a Avesani, Giacomo $u Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy
700    1_
$a Benesova, Klára $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Burgetova, Andrea $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Calareso, Giuseppina $u Department of Radiology, IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, Milan, Italy
700    1_
$a Chiappa, Valentina $u Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
700    1_
$a Cibula, David $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Fagotti, Anna $u Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Rome, Italy
700    1_
$a Franchi, Dorella $u Preventive Gynecology Unit, Division of Gynecology, European Institute of Oncology IRCCS, Milan, Italy
700    1_
$a Frühauf, Filip $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Jarkovsky, Jiri $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Kocian, Roman $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Lambert, Lukas $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Masek, Martin $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Panico, Camilla $u Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy
700    1_
$a Pricolo, Paola $u Division of Radiology, IEO European Institute of Oncology IRCCS, Milan, Italy
700    1_
$a Scambia, Giovanni $u Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Rome, Italy
700    1_
$a Slama, Jiri $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Testa, Antonia Carla $u Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Rome, Italy
700    1_
$a Urbinati, Ailyn Mariela Vidal $u Preventive Gynecology Unit, Division of Gynecology, European Institute of Oncology IRCCS, Milan, Italy
700    1_
$a Garcia, Julio Vara $u Department of Obstetrics and Gynecology, Clínica Universidad de Navarra, Pamplona, Spain
700    1_
$a Vigorito, Raffaella $u Department of Radiology, IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, Milan, Italy
700    1_
$a Fischerová, Daniela $u Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. Electronic address: daniela.fischerova@vfn.cz
773    0_
$w MED00001958 $t Gynecologic oncology $x 1095-6859 $g Roč. 191 (20241010), s. 132-142
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39393218 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104157 $b ABA008
999    __
$a ok $b bmc $g 2263153 $s 1239233
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 191 $c - $d 132-142 $e 20241010 $i 1095-6859 $m Gynecologic oncology $n Gynecol Oncol $x MED00001958
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Archiving options